CRSP logo

CRISPR Therapeutics AG (CRSP) Company Overview

Profile

Full Name:

CRISPR Therapeutics AG

Sector:

Healthcare

Industry:

Biotechnology

Country:

Switzerland

IPO:

October 19, 2016

Indexes:

Not included

Website:

http://www.crisprtx.com

Description:

CRISPR Therapeutics AG is a biotechnology company focused on developing gene-editing therapies using CRISPR technology. They aim to treat genetic diseases by modifying genes in patients' cells. Their research includes treatments for conditions like sickle cell disease and beta-thalassemia, offering hope for new medical solutions.

Key Details

Price

$45.49

Market Cap

$3.90 B(Mid cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$35.00 M(-90.54% YoY)

Annual EPS

-$4.34(-123.71% YoY)

PE Ratio

-

Annual ROE

-19.20%

Annual Debt To Equity

0.00

Beta

1.63

Events Calendar

Earnings

Next earnings date:

May 8, 2025

Recent quarterly earnings:

Feb 11, 2025

Recent annual earnings:

Feb 11, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 19, 25 Cantor Fitzgerald
Neutral
Feb 18, 25 Citigroup
Buy
Feb 14, 25 Morgan Stanley
Underweight
Feb 14, 25 Evercore ISI Group
Outperform
Feb 13, 25 Stifel
Hold
Feb 13, 25 JMP Securities
Market Outperform
Feb 13, 25 HC Wainwright & Co.
Buy
Feb 13, 25 Goldman Sachs
Neutral
Feb 13, 25 Chardan Capital
Buy
Feb 12, 25 Truist Securities
Buy

Screeners with CRSP included

Growing Shares Outstanding
Mid cap stocks
Stocks with high beta
Stocks below SMA 200
Most recommended stocks
Stocks above SMA 50
Stocks below analysts price target
Healthcare sector
All stocks
High Altman Z score stocks

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$45.49
CRSP price is $45.49

Price All-time High

$210.04
CRSP price is currently -78.34% below its historical high of $210.04

Price Analysts Target

$84.00
CRSP price is currently -45.85% lower than the consensus analysts' forecast

Price Most Recent Change

+5.71%
CRSP price was up +5.71% on Mar 8, 2025

Price YTD Change

+15.63%
CRSP price is up +15.63% since January 1st

Price 3-Year Change

-17.59%
CRSP price is down -17.59% over the past 3 years

Market cap

Market Cap

$3.90 B
CRSP market capitalization is $3.90 billion

Market Cap 3-Year Change

-8.28%
CRSP market capitalization is down -8.28% over the past 3 years

Market Cap All-time High

$15.53 B
CRSP market capitalization is currently -74.87% below its historical high of $15.53 billion

Market Cap Sector Rank

87.65%
CRSP market capitalization is higher than 87.65% of companies in Healthcare sector

Technical

Beta

1.63
CRSP beta is 1.63

200-day SMA

$48.91
CRSP price is currently -6.99% below its 200-day simple moving average

14-day RSI

53.74
CRSP 14-day relative strength index is 53.74

30-day Relative Volume

0.74
CRSP 30-day relative volume is 0.74

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$35.00 M
CRSP annual revenue is $35.00 million

Annual Revenue Analysts Estimate

$57.72 M
CRSP annual revenue is currently -39.37% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

-90.54%
CRSP annual revenue is down -90.54% year-on-year

Annual Revenue Sector Rank

44.79%
CRSP annual revenue is higher than 44.79% of companies in Healthcare sector

Profit

Annual Gross Profit

-$75.25 M
CRSP annual gross profit is -$75.25 million

Annual Gross Margin

-215.00%
CRSP annual gross profit margin is -215.00%

Annual Operating Profit

-$466.57 M
CRSP annual operating income is -$466.57 million

Annual Operating Margin

-1333.05%
CRSP annual operating profit margin is -1333.05%

Annual Net Income

-$366.25 M
CRSP annual net profit is -$366.25 million

Annual Net Margin

-1046.43%
CRSP annual net profit margin is -1046.43%

EPS

Annual EPS

-$4.34
CRSP annual earnings per share is -$4.34

Annual EPS Analysts Estimate

-$4.96
CRSP annual earnings per share is currently -12.53% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

-123.71%
CRSP annual earnings per share is down -123.71% year-on-year

Annual EPS Sector Rank

25.75%
CRSP annual earnings per share is higher than 25.75% of companies in Healthcare sector

ROA & ROE

Annual ROA

-16.38%
CRSP annual return on assets is -16.38%

Annual ROE

-19.20%
CRSP annual return on equity is -19.20%

EBIT & EBITDA

Annual EBIT

-$466.57 M
CRSP annual earnings before interest & taxes is -$466.57 million

Annual EBITDA

-$447.31 M
CRSP annual EBITDA is -$447.31 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
CRSP price to earnings ratio value is unknown

PE Ratio Sector Rank

-
CRSP price to earnings ratio is unknown

PB Ratio

PB Ratio

2.02
CRSP price to book ratio is 2.02

PB Ratio Sector Rank

59.72%
CRSP price to book ratio is higher than 59.72% of companies in Healthcare sector

PS Ratio

PS Ratio

111.48
CRSP price to sales ratio is 111.48

PS Ratio Sector Rank

95.57%
CRSP price to sales ratio is higher than 95.57% of companies in Healthcare sector

Enterprise value

Enterprise Value

$3.83 B
CRSP enterprise value is $3.83 billion

Enterprise Value Sector Rank

86.22%
CRSP enterprise value is higher than 86.22% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-8.56
CRSP EV/EBITDA is -8.56

EV/EBITDA Sector Rank

14.71%
CRSP EV/EBITDA is higher than 14.71% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

22.07
CRSP annual current ratio is 22.07

Annual Quick Ratio

-
CRSP annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.00
CRSP annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-
CRSP annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
CRSP piotroski f-score value is unknown

Altman Z-Score

7.02
CRSP altman z-score is 7.02

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$2.24 B
CRSP annual total assets is $2.24 billion

Annual Non Current Assets

$304.90 M
CRSP annual long term assets is $304.90 million

Annual Current Assets

$1.94 B
CRSP annual total current assets is $1.94 billion

Annual Cash & Cash Equivalents

$298.26 M
CRSP annual cash & cash equivalents is $298.26 million

Equity

Annual Book Value

$1.93 B
CRSP annual book value is $1.93 billion

Annual Working Capital

$1.85 B
CRSP annual working capital is $1.85 billion

Liabilities

Annual Total Liabilities

$309.95 M
CRSP annual total liabilities is $309.95 million

Annual Total Long Term Liabilities

$222.17 M
CRSP annual total long term liabilities is $222.17 million

Annual Current Liabilities

$87.78 M
CRSP annual total current liabilities is $87.78 million

Annual Accounts Payable

$14.71 M
CRSP annual accounts payable is $14.71 million

Debt

Annual Total Debt

$223.69 M
CRSP annual total debt is $223.69 million

Annual Total Debt 1-Year Change

-6.26%
CRSP annual total debt is down -6.26% year-on-year

Annual Long Term Debt

$206.41 M
CRSP annual long term debt is $206.41 million

Annual Short Term Debt

$17.29 M
CRSP annual short term debt is $17.29 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$501.57 M
CRSP annual total expenses is $501.57 million

Annual Operating Expenses

$391.32 M
CRSP annual total operating expenses is $391.32 million

Annual Cost Of Goods Sold

$110.25 M
CRSP annual cost of goods sold is $110.25 million

Annual SGA

$72.98 M
CRSP annual SGA is $72.98 million

Annual D&A

$19.26 M
CRSP annual depreciation & amortization is $19.26 million

Annual Interest Expense

-
CRSP annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$142.77 M
CRSP annual cash flow from operations is -$142.77 million

Annual CFO 1-Year Change

+45.17%
CRSP annual cash flow from operations is up +45.17% year-on-year

Annual CFI

-$280.48 M
CRSP annual cash flow from investing activities is -$280.48 million

Annual CFI 1-Year Change

-174.87%
CRSP annual cash flow from investing activities is down -174.87% year-on-year

Annual CFF

$331.98 M
CRSP annual cash flow from financing activities is $331.98 million

Annual CFF 1-Year Change

+429.78%
CRSP annual cash flow from financing activities is up +429.78% year-on-year

Free CashFlow

Annual FCF

-$144.68 M
CRSP annual free cash flow is -$144.68 million

Annual FCF 1-Year Change

+46.88%
CRSP annual free cash flow is up +46.88% year-on-year

CAPEX

Annual CAPEX

$1.90 M
CRSP annual capital expenditures is $1.90 million

Annual CAPEX 1-Year Change

-84.12%
CRSP annual capital expenditures is down -84.12% year-on-year

Institutional Ownership

Similar stocks

ACLX logo
Arcellx (ACLX)
ZLAB logo
Zai Lab Limited (ZLAB)
ADMA logo
ADMA Biologics (ADMA)
OGN logo
Organon & Co (OGN)
SWTX logo
SpringWorks Therapeutics (SWTX)
OSCR logo
Oscar Health (OSCR)
PRGO logo
Perrigo (PRGO)
ITGR logo
Integer Holdings (ITGR)
RDNT logo
RadNet (RDNT)

FAQ

  • What is the ticker symbol for CRISPR Therapeutics AG?
  • Does CRISPR Therapeutics AG pay dividends?
  • What sector is CRISPR Therapeutics AG in?
  • What industry is CRISPR Therapeutics AG in?
  • What country is CRISPR Therapeutics AG based in?
  • When did CRISPR Therapeutics AG go public?
  • Is CRISPR Therapeutics AG in the S&P 500?
  • Is CRISPR Therapeutics AG in the NASDAQ 100?
  • Is CRISPR Therapeutics AG in the Dow Jones?
  • When was CRISPR Therapeutics AG's last earnings report?
  • When does CRISPR Therapeutics AG report earnings?
  • Should I buy CRISPR Therapeutics AG stock now?

What is the ticker symbol for CRISPR Therapeutics AG?

The ticker symbol for CRISPR Therapeutics AG is NASDAQ:CRSP

Does CRISPR Therapeutics AG pay dividends?

No, CRISPR Therapeutics AG does not pay dividends

What sector is CRISPR Therapeutics AG in?

CRISPR Therapeutics AG is in the Healthcare sector

What industry is CRISPR Therapeutics AG in?

CRISPR Therapeutics AG is in the Biotechnology industry

What country is CRISPR Therapeutics AG based in?

CRISPR Therapeutics AG is headquartered in Switzerland

When did CRISPR Therapeutics AG go public?

CRISPR Therapeutics AG's initial public offering (IPO) was on October 19, 2016

Is CRISPR Therapeutics AG in the S&P 500?

No, CRISPR Therapeutics AG is not included in the S&P 500 index

Is CRISPR Therapeutics AG in the NASDAQ 100?

No, CRISPR Therapeutics AG is not included in the NASDAQ 100 index

Is CRISPR Therapeutics AG in the Dow Jones?

No, CRISPR Therapeutics AG is not included in the Dow Jones index

When was CRISPR Therapeutics AG's last earnings report?

CRISPR Therapeutics AG's most recent earnings report was on Feb 11, 2025

When does CRISPR Therapeutics AG report earnings?

The next expected earnings date for CRISPR Therapeutics AG is May 8, 2025

Should I buy CRISPR Therapeutics AG stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions